MYM Nutraceuticals Inc.

(CSE:MYM.CN) (OTCQB:MYMMF)

Get Top Rated Stock Alerts Active Traders Depend On

Sign Up Today For FREE News Driven Alerts

MYM Provides Update on 120-Acre CBD-Rich Hemp Project in Nevada

Vancouver, BC – June 13, 2019– MYM Nutraceuticals Inc., (CSE: MYM) (OTCBB: MYMMF) (“MYM” or “The Company”) Is pleased to provide an update on its CBD-rich hemp project situated on 120 acres in Nye County, Nevada.

 

Further to the announcement of April 30, 2019, the 1.6 million CBD-rich hemp seeds MYM and Elite Ventures acquired have spent the last six weeks in the greenhouse germinating. The seeds have sprouted and grown into seedlings that are currently being prepped for planting.

 

The 120-acre pivot (crop circle) has been amended and prepped, ready for cultivation. A crop of red clover has been planted to be used as a cover crop to protect the seedlings. All of the equipment, including the auto-planters, has been prepped and the project will now move to the planting stage.

 

“The 1.6 million CBD-rich seeds we acquired in April have now sprouted and are ready to go into the ground for the 2019 growing season,” said Howard Steinberg, CEO of MYM. “The Nevada project is a key component in our strategy to create a massive CBD-rich hemp footprint around the globe with the goal of becoming one of the largest cultivators and bulk CBD isolate suppliers in the world.”

 

The Company’s Nevada project is based on a CBD-rich hemp production agreement with immediate revenue-generating potential. MYM has partnered with Elite Ventures and invested USD $500,000 to grow one pivot of 120 acres of CBD-rich hemp in Nevada. Elite will plant, grow, harvest, and process the hemp into CBD isolate of which MYM is entitled to 50%

 

Based on previous crops grown on the property, MYM’s 50% entitlement of the estimated production is 60,000 lbs of biomass to be converted into 2,694 lbs of CBD isolate per harvest with potential revenue of $7.1 million for the 2019 grow season. MYM’s estimated profit for the 2019 grow season is $5.4 million.

 

About MYM Nutraceuticals Inc.

MYM Nutraceuticals Inc. is an innovative company focused on the global growth of Cannabis and hemp. To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors. MYM shares trade in Canada, Germany and the USA under the following symbols: (CSE:MYM) (OTC:MYMMF) (FRA:0MY) (DEU:0MY) (MUN:0MY) (STU:0MY).

 

ON BEHALF OF THE BOARD

 

Howard Steinberg, CEO

MYM Nutraceuticals Inc.

www.mym.ca

 

Investor Relations

Billy Casselman

778-522-2261

investors@mym.ca

 

Keep up to date with MYM on our social media channels:

 

Twitter: @mymnutra

Facebook: @mymnutra

Instagram: @mymnutra

 

This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.

 

This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE), accepts responsibility for the adequacy or accuracy of this release.

 

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities law and may not be offered or sold in the “United States”, as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.

 

Source:  MYM Nutraceuticals Inc.

MYM Announces Commitments to Fully Fund its Strategic Plan Through 2020

Vancouver, BC –  June 11, 2019– MYM Nutraceuticals Inc. (“MYM” or “The Company”) (CSE: MYM) (OTCQB: MYMMF) is pleased to announce that it has commitments totaling $9.5 million in financing, which will fully fund its strategic plan through 2020. The $9.5 million is a mixture of $5.5 million of debt from Trichome Financial Corp (“Trichome Financial” or “Trichome”) and $4 million of equity from Alumina Partners LLC (“Alumina Partners”).

 

“MYM is encouraged to share that, after considerable due diligence, Trichome Financial and Alumina Partners have decided to provide the company with commitments to finance up to $9.5 million,” said Howard Steinberg, CEO of MYM. “The commitments are an incredible vote of confidence for our plans to become global leaders in the cultivation, extraction, and distribution of CBD-rich hemp. The capital raise is a significant milestone that allows the Company to fully fund our strategic plan through 2020.”

 

MYM currently has three CBD-rich hemp cultivation and extraction projects, two medical cannabis cultivation projects, and three CBD isolate distribution offices in Mexico, Australia, and Europe. Through 2020, the plan forecasts cultivating over 5 million pounds of CBD rich biomass that if converted into isolate, as per the plan, will produce 108,800 kilograms of CBD isolate. Visit mym.ca for more details on the 2019 Strategic Plan.

 

”We have been thoroughly impressed with the level of expertise and sophistication that MYM’s new senior leadership team has displayed as they execute a pivot towards becoming leaders in all aspects of CBD-rich hemp” said Michael Ruscetta, CEO of Trichome.  “This transaction is another example of Trichome providing flexible and timely capital fully secured against all the assets and licenses of MYM, which we expect will deliver extremely attractive returns”

 

 

“Alumina is excited to support MYM as they accelerate the execution of their comprehensive hemp-derived cannabidiol strategy,” added Adi Nahmani, Managing Member of Alumina Partners. “The explosion in popularity and wide range of consumer applications of CBD, coupled with its increasingly favorable regulatory outlook, make this a key focus for MYM. We are confident that the strategic plan that management is executing upon will contribute enormously to future revenue.”

 

The Trichome financing (“Trichome Financing”) is in the form of a senior secured term loan with an interest a rate of 12% per annum and which matures in 12 months following closing, with an option to extend for another 6 months.  In connection with the Trichome Financing, MYM will issue up to 5,000,000 warrants in three tranches. Each warrant entitles the holder to purchase one common share of the Company at a price of $0.30 for a period of three years from the date of issue. Closing of the Trihcome Financing is subject to MYM’s receipt of a cultivation license from Health Canada for their 10,000 sq. ft. facility in Laval, Quebec, definitive documentation, along with other customary conditions precedent.

 

The Alumina Partners financing is a firm commitment, subject to the granting of our license from Health Canada and certain customary market outs and other conditions, to fund up to $4 Million under the terms of the existing Alumina Equity Agreement previously announced.

 

About Trichome Financial Corp.

Trichome is a specialty finance company focused on providing flexible and creative capital solutions to the global legal cannabis market. Trichome was created to address the lack of credit availability in the large, growing and increasingly complex cannabis market. Founded by industry leaders Origin House and Stoic Advisory, Trichome’s experienced management team has a unique edge to capitalize on proprietary deal flow and industry insight while developing a first mover advantage as a global cannabis-focused specialty finance company. Trichome provides customized financing solutions across the industry value chain to support growth, capital expenditures, mergers, acquisitions, working capital and other needs. Leveraging the combined resources and knowledge of its founders, it is able to offer significant value-added financial, product, market and operational support to its partner companies. Trichome’s current assets are all based in Canada and it has no operations or assets in the United States. For more information, please visit www.trichomefinancial.com or @trichomefinance on Twitter.

 

About Alumina Partners LLC

Alumina Partners is a New York-based private investment partnership of experienced accredited investors who came together to bring sensible, responsive and non-disruptive institutional investment back to the emerging growth arena. They work diligently with the companies they invest in to better understand the challenges those companies face and the unique opportunities they can take advantage of when well-capitalized. Alumina has been an early and very active investor in the Canadian regulated cannabis space.

 

About MYM Nutraceuticals Inc.

MYM Nutraceuticals Inc. is an innovative company focused on the global growth of Cannabis and CBD-rich hemp. To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors. MYM shares trade in Canada, Germany and the USA under the following symbols: (CSE:MYM) (OTC:MYMMF) (FRA:0MY) (DEU:0MY) (MUN:0MY) (STU:0MY).

 

ON BEHALF OF THE BOARD

 

Howard Steinberg, CEO

MYM Nutraceuticals Inc.

www.mym.ca

 

Investor Relations

Billy Casselman

778-522-2261

investors@mym.ca

 

Keep up to date with MYM on our social media channels:

 

Twitter: @mymnutra

Facebook: @mymnutra

Instagram: @mymnutra

 

This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results including the timing of the receipt of funds and interest payments and the receipt of a cultivation license from Health Canada. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.

 

This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE), accepts responsibility for the adequacy or accuracy of this release.

 

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities law and may not be offered or sold in the “United States”, as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.

 

Source:  MYM Nutraceuticals Inc.

MYM and One World Ventures Inc. Form “MYM One World LLC” to Cultivate, Extract and Distribute 3,000 Acres of CBD-Rich Hemp on the Navajo Nation

Vancouver, BC –  April 25, 2019 – MYM Nutraceuticals Inc., (CSE: MYM) (OTCBB: MYMMF) (“MYM” or “The Company”) is pleased to announce the formation of a Nevada Company, MYM One World LLC, to facilitate the joint multi-year co-operative agreement between MYM and Aqueous Sciences, a subsidiary of One World Ventures Inc (OWVI). The company and memorandum of understanding is to cultivate, extract & distribute 3,000 acres of hemp on Navajo Nation land located near the four corners area of Colorado, Arizona, Utah and New Mexico, USA.

 

The purpose of organizing a new company to cultivate, extract, and distribute hemp is so each corporation will own 50%. MYM and Aqueous also plan to extend their activities to include the extraction, manufacture and distribution of hemp based products that will comply with Navajo Nation, USDA, FDA and FTC regulations and requirements.

 

“Our partnership with Aqueous to cultivate 3,000 acres of CBD-rich hemp has taken another step forward today with the formation of MYM One World LLC”, said Howard Steinberg, CEO of MYM. “Our team is currently preparing the fields for the 2019 growing season. We’re looking forward to exceeding the results of last year’s test crop that was successful in growing an abundance of CBD-rich hemp”.

 

MYM and Aqueous are funding the venture with up to an initial amount of $2,000,000 USD for operating and capital costs.

 

Aqueous is providing all labour, site management, and other resources as necessary to operate the business. Aqueous will ensure all regulatory approvals and compliance necessary to successfully cultivate legal hemp plants upon the Navajo Nation. MYM is providing expertise and support in growing procedure, import/export facilitation, access to its research and development team, and distribution.

 

“We are very excited about the formation of MYM One World LLC and preparing the fields to plant lab tested, CBD-rich hemp seeds as we speak”, said DaMu Lin, CEO of OWVI. “As legal production of cannabis is rapidly increasing worldwide, so has the demand for hemp derived products and these experienced farmers along with their 200,000 acres of irrigated, ready to grow fields, are ready to jump in”.

 

“This is a step forward for our Navajo farmers and Native America in revitalizing our traditional culture within an agricultural context and to be part of this emerging industry”, added Dineh Benally, President of the Navajo Nation San Juan River Farm Board. “Exercising Sovereignty, Traditional and Fundamental Law with a legal, compliant hemp framework in place that also considers their traditional crops and growing season, the Navajo and all Native people around the world can be in a better position to improve their economy of their communities by participating in this global business venture ”

 

For more information visit

www.oneworldventuresinc.com

www.mym.ca

www.nativeamericanagriculture.com

www.aqueousic.com

 

MYM announces it has closed a non-brokered private placement as part of a series of drawdowns on the Alumina Equity Agreement consisting of 1,341,200 units at a price of CAD$0.44 per unit for gross proceeds of $590,128.00.

 

Each unit consists of one common share and one transferable common share purchase warrant.  Each warrant entitles the holder to purchase one common share at a price of $0.69 for a period of three years from the issue date. The warrants are subject to an acceleration provision that allows the Company to give notice of an earlier expiry date if the Company’s share price on the Canadian Securities Exchange (or such other stock exchange the Company may be trading on) is equal or greater than $1.38 for a period of 10 consecutive trading days. The securities will be subject to a four month and one day hold period under securities laws.

 

The Company intends to use the proceeds from the private placement to fund the initial operations of MYM One World LLC and for general and other working capital purposes.

 

About MYM Nutraceuticals Inc.

MYM Nutraceuticals Inc. is an innovative company focused on the global growth of Cannabis and hemp.  To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors. MYM shares trade in Canada, Germany and the USA under the following symbols: (CSE:MYM) (OTC:MYMMF) (FRA:0MY) (DEU:0MY) (MUN:0MY) (STU:0MY).

 

ON BEHALF OF THE BOARD

 

Howard Steinberg, CEO

MYM Nutraceuticals Inc.

www.mym.ca

 

Investor Relations

Billy Casselman

778-522-2261

investors@mym.ca

 

Keep up to date with MYM on our social media channels:

 

Twitter: @mymnutra

Facebook: @mymnutra

Instagram: @mymnutra

 

This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.

 

This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE), accepts responsibility for the adequacy or accuracy of this release.

 

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities law and may not be offered or sold in the “United States”, as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.

 

Source:  MYM Nutraceuticals Inc.

MYM Launches Updated 2019 Strategic Plan

Vancouver, BC –  April 4, 2019– MYM Nutraceuticals Inc., (CSE: MYM) (OTCQB: MYMMF) (“MYM” or “The Company”) is pleased to announce it has updated its 2019 strategic plan. The updated plan can be found at the Company’s website, mym.ca, under the “Investors” tab. Highlights include MYM plans for global cultivation, extraction, distribution, and the creation of unique brands.

 

MYM is positioning itself to become a global leader in cannabis, hemp, and seed cultivation through a variety of global partnerships in agricultural friendly zones around the world. We bring to each partnership our expertise in cultivation (indoor, outdoor & greenhouse), and extraction combined with global distribution and unique brands allowing us to leverage our knowledge worldwide.

 

By creating strategic geographic partnerships around the world, MYM is in a prime position to take advantage of cultivating in low cost regions while distributing in high revenue regions thereby maximizing profits.

 

In addition to information indicated in the plan, we are in the midst of negotiating a number of agreements for cannabis and hemp production and distribution in North America, South America and the South Pacific. The Company anticipates these will be announced shortly.

 

“Key additions to senior management offer an opportunity to focus the Company’s efforts on new projects around the globe,” said Howard Steinberg, CEO of MYM. “Our updated plan includes a targeted focus on low-cost cannabis and hemp production sites across the globe while distributing into countries with high revenue potential thereby maximizing profits.”

 

About MYM Nutraceuticals Inc.

MYM Nutraceuticals Inc. is an innovative company focused on the global growth of Cannabis and hemp.  To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors.  MYM shares trade in Canada, Germany and the USA under the following symbols: (CSE:MYM) (OTC:MYMMF) (FRA:0MY) (DEU:0MY) (MUN:0MY) (STU:0MY).

 

ON BEHALF OF THE BOARD

 

Howard Steinberg, CEO

MYM Nutraceuticals Inc.

www.mym.ca

 

Investor Relations

Billy Casselman

778-522-2261

investors@mym.ca

 

Keep up to date with MYM on our social media channels:

 

Twitter: @mymnutra

Facebook: @mymnutra

Instagram: @mymnutra

 

This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.

 

This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE), accepts responsibility for the adequacy or accuracy of this release.

 

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities law and may not be offered or sold in the “United States”, as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.

 

Source:  MYM Nutraceuticals Inc.

MYM Increases Stake in Colombia Organica to 80%

Vancouver, BC – March 20, 2019 – MYM Nutraceuticals Inc., (CSE: MYM) (OTCQB: MYMMF) (“MYM” or “The Company”) is pleased to announce that it has increased its stake in Colombia Organica to 80%.

 

Colombia Organica currently holds 3 licenses which include: production of cannabis derivatives, cultiviation of psychoactive cannabis, and cultiviation of non-psychoactive cannabis. All licenses include the capacity to export. Colombia Organica has submitted an application to certify cannabis seeds for commercialization. In addition, it holds a lease for a 36-acre property located 44 kms from Medellin. The region’s climate is conducive for growing cannabis with an average temperature of 16-18 °C, and an elevation of 2,475 meters above sea-level. They have secured an option to buy the property.

 

MYM and Colombia Organica are building a production facility near Medellin, Colombia for the cultivation and processing of cannabis and cannabis products. Currently, Colombia Organica is developing and registering seed strains with the Colombian Agricultural Institute.

 

MYM will acquire eighty 80% of Colombia Organica  from its existing shareholders for consideration of cash, equity and loans to the company for a total package of up to $2.26 million. MYM will employ Colombia Organica principals Daniel Alonso and Gabriel Ramirez as Territory Managers for South American operations.

 

“After further review we’ve decided to increase our stake in Colombia Organica under much more favourable terms”, said Howard Steinberg, CEO of MYM. “Colombia presents an exciting opportunity for MYM to expand its cultivation operations into South America, bringing with it increased value to our shareholders. The addition of Daniel and Gabriel to our team will provide the company with boots on the ground for all current and future projects in South America”.

 

The Investment Agreement is subject to all required approvals and MYM’s due diligence.

 

About Colombia Organica

Colombia Organica is a Colombian company with expertise in the manufacture of pharmaceutical products, medicinal chemical substances and botanical products.  The Company holds a seed to sale license for low THC cannabis and is in the application process for both high THC cannabis cultivation and extraction. Colombia Organica has selected for production high quality plants which are suited to the unique high altitude, equatorial regions of Antioquia, Colombia.

 

About MYM Nutraceuticals Inc.

MYM Nutraceuticals Inc. is an innovative company focused on the global growth of cannabis and hemp.  To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors.  MYM shares trade in Canada, Germany and the USA under the following symbols: (CSE:MYM) (OTC:MYMMF) (FRA:0MY) (DEU:0MY) (MUN:0MY) (STU:0MY).

ON BEHALF OF THE BOARD

 

Howard Steinberg, CEO

MYM Nutraceuticals Inc.

www.mym.ca

 

Investor Relations

Billy Casselman

778-522-2261

investors@mym.ca

 

Keep up to date with MYM on our social media channels:

 

Twitter: @mymnutra

Facebook: @mymnutra

Instagram: @mymnutra

 

This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.

 

This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE), accepts responsibility for the adequacy or accuracy of this release.

 

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities law and may not be offered or sold in the “United States”, as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.

 

Source: MYM Nutraceuticals Inc.,

MYM Enters Into Agreement to Grow CBD-Rich Hemp in Nevada

Vancouver, BC –  March 7, 2019 – MYM Nutraceuticals Inc. (CSE: MYM) (OTCQB: MYMMF) (“MYM” or “The Company”) is pleased to announce it has entered into an agreement with Elite Ventures Group (“Elite”) to grow 120 acres of CBD-rich hemp in Nevada, USA.

 

Under the agreement, MYM will fund Elite with $500,000 USD in exchange for the rights to 50% of CBD rich hemp grown on a 120 acre parcel of land in Nevada. In consideration for the investment, Elite will provide all the necessary capital and consumable supplies, plant, grow and harvest the hemp. If requested, Elite will also arrange for the processing and sale of the biomass at no less favourable terms than those found in the Elite supply agreements.

 

Based on Elite’s previous success in cultivating 120 acres of similarly situated land in August 2018, the estimated production of hemp from the MYM parcel of land is 120,000 pounds per harvest with a CBD level of 10%-19%. This represents potential revenue of over $26 million, of which MYM is entitled to 50% less processing and sales fees.

 

“We are delighted to have entered into this agreement with Elite Ventures,” said Howard Steinberg, CEO of MYM. “This agreement signals an important step forward in our plan to be a significant cultivator of hemp to satisfy the increasing demand of biomass and CBD worldwide.”

 

About MYM Nutraceuticals Inc.

MYM Nutraceuticals Inc. is an innovative company focused on the global growth of cannabis and hemp.  To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors.  MYM shares trade in Canada, Germany and the USA under the following symbols: (CSE:MYM) (OTC:MYMMF) (FRA:0MY) (DEU:0MY) (MUN:0MY) (STU:0MY).

 

ON BEHALF OF THE BOARD

 

Howard Steinberg, CEO

MYM Nutraceuticals Inc.

www.mym.ca

 

Investor Relations

Billy Casselman

778-522-2261

investors@mym.ca

 

Keep up to date with MYM on our social media channels:

 

Twitter: @mymnutra

Facebook: @mymnutra

Instagram: @mymnutra

 

This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.

 

This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE), accepts responsibility for the adequacy or accuracy of this release.

 

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities law and may not be offered or sold in the “United States”, as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.

 

Source:  MYM Nutraceuticals Inc.,

MYM Nutraceuticals, New Manufacturing Facility for Cannabis Consumables, CEO Clip Video

Vancouver, British Columbia–(Newsfile Corp. – November 2, 2018) – Rob Gietl, CEO of MYM Nutraceuticals explains how their cannabis company aims to focus on the medical industry.

 

https://www.youtube.com/v/IyvpW1GYYn8

 

If you cannot view the video above, please visit:
https://www.b-tv.com/mym-nutraceuticals-ceo-clips-90sec/

 

MYM Nutraceuticals is being featured on BNN Bloomberg on Nov. 3 – Nov. 4, 2018 Monday through Friday, throughout the day and evenings.

 

MYM Nutraceuticals (CSE: MYM)

www.mym.ca

 

About CEO Clips:

CEO Clips is the largest library of publicly traded company CEO videos in Canada and the US. These 90 second video profiles broadcast on national TV and online via 15 top financial sites including: Thomson Reuters, Bloomberg, Yahoo! Finance and Stockhouse.com.

 

BTV – Business Television/CEO Clips Contact: Trina Schlingmann (604) 664-7401 x 5 trina@b-tv.com

http://www.newsfilecorp.com/newsinfo.php?i=40829&f=130

MYM Appoints Howard Steinberg as Independent Director and Vice-Chairman of the Company

VANCOUVER, British Columbia, Oct. 24, 2018 /PRNewswire/ — MYM Nutraceuticals Inc., (CSE: MYM) (CSE: MYM.CN) (the “Company” or “MYM”) is pleased to announce the appointment of Howard Steinberg as independent Director and Vice-Chairman of the Company, effective October 24, 2018.

 

Mr. Steinberg has more than 20 years investment experience as a senior executive, working within some of the largest financial institutions in the world. He has sat on over a dozen Boards including his current role as Executive Chairman of Parallax Developments Corp. He has invested personally and with global financial institutions in a wide range of industries in every area of the balance sheet. Mr. Steinberg has an MBA from the University of Western Ontario and is a CFA charterholder.

 

“It is with great excitement that I join the MYM team,” said Howard Steinberg. “Bringing in leadership such as myself is a key step in the transformation process to realize our shared vision of becoming an industry leader. Together, I’m confident we can get there.”

 

“It is an honour to welcome Howard to the MYM team,” said Rob Gietl, CEO of MYM. “Howard brings with him a wealth of experience as a senior executive in a variety of businesses. His time spent in global finance and tenure as Executive Chairman of Parallax have put him in a prime position to help lead MYM to success with our projects around the world.”

 

Mr. Steinberg was granted options to purchase 3,000,000 common shares of the Company in accordance with the Company’s stock option plan for a period of four years. The options are exercisable at a price of $1.10 per share. 250,000 options will vest in a single tranche immediately. 250,000 options will vest every three months thereafter. Subject to Mr. Steinberg meeting certain targets within the first 12 months of his appointment, the options will vest immediately. The expiry date of these options is October 24, 2022.

 

About MYM Nutraceuticals Inc.

MYM Nutraceuticals Inc. is an innovative company focused on acquiring Health Canada licenses to produce and sell high-end medicinal cannabis supplements and topical products. MYM is a shareholder in two production projects in Quebec that are anticipated to have over 1.5 million square feet of production space. MYM is also a shareholder in a cannabis production project in Australia. The “Northern Rivers Project” in New South Wales, Australia is expected to have 1.2 million square feet of cannabis production space. To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors. MYM shares trade in Canada, Germany and the USA under the following symbols: (CSE:MYM) (OTC:MYMMF) (FRA:0MY) (DEU:0MY) (MUN:0MY) (STU:0MY).

 

ON BEHALF OF THE BOARD

Rob Gietl, CEO
MYM Nutraceuticals Inc.
www.mym.ca

 

Keep up to date with MYM on our social media channels:

Twitter: @mymnutra

Facebook: @mymnutra

Instagram: @mymnutra

 

This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.

 

This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE), accepts responsibility for the adequacy or accuracy of this release.

 

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities law and may not be offered or sold in the “United States”, as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.

 

Investor Relations

Brian Tasker
+1-403-616-1045
brian.tasker@mym.ca

 

 

SOURCE MYM Nutraceuticals Inc.

About MYM Nutraceuticals

MYM Nutraceuticals is focused on constructing high quality cannabis growing facilities while building, acquiring, and growing businesses to become a world-class cannabis brand.

 

 

PRODUCTION FACILITIES

 

MYM through its various joint ventures is currently building three large-scale production facilities in both Canada and Australia. Upon completion of these three projects, the total amount of greenhouse growing space is expected to exceed 2.7 million square feet.

 

The Weedon Project
Weedon, Quebec

 

The Weedon Project – The 1.5 million sf greenhouse project has been approved by the City of Weedon. A license application has been submitted to Health Canada. MYM has purchased through its partially owned subsidiaries 329 acres of land to build on. This project will include a cannabis museum and a cannabis university for industry training.

 

The Laval Project
Laval, Quebec

 

The Laval Project – The facility has been completed and is awaiting licensing from Health Canada. The facility is currently 10,000 sf and will be expanded to 37,000 sf. Once the appropriate licenses are received from Health Canada, it will enable MYM to produce and market its branded THC and CBD medical products across Canada.

 

The Northern Rivers Project
Casino, New South Wales, Australia

 

The Northern Rivers Project owned by Solaris Nutraceuticals – a 1.2 million sf greenhouse project which, upon completion, is expected to be the largest cannabis greenhouse in Australia. Subject to receiving the appropriate licenses, the first crop is expected to be planted in the second quarter of 2019. Solaris Nutraceuticals received a AUD $2,500,000 grant from Federal Department of Innovation, Industry & Science for this project. MYM owns 35% of Solaris Nutraceuticals – www.solarisnutraceuticals.com

 

Colombia ORGANICA
Medellin, Colombia

 

MYM has purchased a 49% stake in Colombia ORGANICA, a Colombia based company with expertise in the manufacturing of pharmaceutical products, medicinal chemical substances and botanical products. Colombia ORGANICA holds a seed to sale license for low THC cannabis and is in the application process for both high THC cannabis cultivation and extraction. Colombia ORGANICA has existing licensing permits to grow, produce and create cannabis derivatives to be commercialized and/or exported. The company will continue to focus on production of high quality plants that are suited to the unique high altitude, equatorial regions of Antioquia, Colombia. Colombia ORGANICA is in the process of developing and registering seed strains with the Colombia Agriculture Institute.

 

MJT Manufacturing
Toronto, Ontario

 

MJT Manufacturing Project – the 5,000 SF production facility located in Toronto, Ontario is a GMP certified, state of the art extraction lab and production facility dedicated to industrial hemp processing (CBD). This high capacity production space is able to produce large volumes with a high level of consistency. The facility is capable of producing a full range of CBD extracts and isolates. The MJT production facility is focussed on product development for MYM owned brand.

 

 

MANAGEMENT TEAM

 

Erick Factor | Executive Chairman

 

Mr. Erick Factor has been appointed to the Company’s Board of Directors and will also serve as Executive Chairman. Mr. Factor is a well-known expert in the cannabis industry and has 20 years of experience in cultivating medical marijuana and manufacturing cannabis by-products, and has provided medical marijuana to thousands of patients over the past two decades. Mr. Factor is also the founder of the “Westcoast Medicann” dispensary, one of just a handful of dispensaries in Vancouver to be licensed under the City of Vancouver’s stringent bylaws. He has extensive experience working with Health Canada, from whom he has obtained MMAR and MMPR licenses for hundreds of patients, and has managed and operated grow facilities to produce for those patients. Mr. Factor has also gained invaluable experience over the past three years in ACMPR licensing regulations and applications.

 

 

Howard Steinberg | Vice-Chairman & Independant Director

 

Mr. Steinberg has more than 20 years investment experience as a senior executive, working within some of the largest financial institutions in the world. He has sat on over a dozen Boards including his current role as Executive Chairman of Parallax Developments Corp. He has invested personally and with global financial institutions in a wide range of industries in every area of the balance sheet. Mr. Steinberg has an MBA from the University of Western Ontario and is a CFA charterholder.

 

 

Rob Gietl | CEO & Director

 

Mr. Gietl was most recently the Director of Business Development at NRI Global Inc. where he headed up multi-million dollar industrial acquisitions, environmental remediation and global sales of reusable assets and commodities. His skills in negotiations and plan development enabled him to leverage partnerships to accelerate expansion and facilitate synergy in execution. Mr. Gietl is well known for his ability to exponentially grow businesses including the west coast franchise expansion of Dominos Pizza, where he Consistently grew the annual business to achieve 300+% increases year over year. Mr. Gietl is a seasoned Business Development and Operations executive with a diverse track record of leading change across all areas of concept creation, brand re-positioning, market penetration, fiscal accountability and efficient execution of business plans. He has grown business effectiveness in an array of sectors and circumstances throughout Canada, consistently aligned with stakeholders goals and values.

 

 

Craig Lennox | CFO

 

Craig Lennox is a proven leader with an extensive background in financial management and operations. Mr. Lennox was most recently CFO at Clearly, a leading online optical retailer. He is a Chartered Professional Accountant and holds a Bachelor of Commerce degree from Queen’s University. He worked at Ernst & Young LLP in Toronto and Vancouver serving both public and private companies. Mr. Lennox spent over 5 years at The Jim Pattison Group Corporate Office in various senior financial roles. Mr. Lennox joined Clearly (Coastal Contacts Inc. – TSX listed) in 2012 as Vice-President of Finance where he was involved in building the business, listing the Company on the Nasdaq and in the ultimate sale of the company in April 2014 to Essilor for $430m. Mr. Lennox became Chief Financial Officer at Clearly in April 2014 and held that role until joining MYM.

 

 

Charith Adkar | CSO

 

Charith Adkar completed his PhD in Plant Biology and Crop Production from the University of Milano, Italy with the specialization in Molecular Plant Pathology. He has done his postdoctoral studies at Hirosaki University, Japan and Université de Sherbrooke, Canada. His areas of expertise include: Plant Science, Biotechnology, Microbiology, Molecular host-pathogen interactions and Bioinformatics. His career highlights include the development of molecular diagnostic kits for the detection of pathogens, studies on molecular basis of pathogenesis of non-coding RNAs. His work has featured in more than 45 scientific publications, a book chapter and a filed patent as a co-inventor. He has given several invited talks at national and international scientific meetings as well as at universities. He is a member of several international and national professional societies and serves as a scientific reviewer in high- impact biological science journals. He has received several prestigious fellowships such as Japan Society for promotion of Sciences (JSPS) Postdoctoral Fellowships for Foreign Researchers,Fondsqueb́ećoisdelarecherchesurlanatureetlestechnologies(FQRNT), Quebec, Canada. He also received the best research article award from the Phytopathological Society of Japan and Journal of General plant pathology for the research article for the year 2015

 

 

Edward Tabisz | Independent Director

 

Mr. Tabisz is an Executive with TD Bank with over 15 years experience in Retail Distribution, Product Management, Finance and Operations. Mr. Tabisz currently leads the Finance team supporting the Real Estate Secured Lending business. Prior to, as an executive with TD Insurance, he led the strategic development and change management of their Life and Health product suite, the culmination of which resulted in an industry Six Sigma process improvement award. Mr. Tabisz graduated from the University of Manitoba in 2001 with more recent on- going continuous learning through Schulich School of Business, York University Executive Education Centre. Mr. Tabisz joins MYM’s board of directors effective May 1, 2018.

 

 

Elizabeth Liu, QC | Independent Director

 

Ms. Elizabeth Liu founded and is Managing Director of LINK Business Law Group, a law firm that provides a broad range of legal, strategic and risk management advice, as well as general counsel services. Her clients include both early-stage and established companies in a variety of industries.

 

Prior to establishing LINK Business Law Group, Ms. Liu was Managing Partner at Basham Thompson & Liu LLP, a boutique litigation firm. She then served as Vice President and General Counsel to the Flora Group of Companies where she was involved in all aspects of the group’s operations and provided guidance on contracts and other legal and risk planning issues. Flora manufactures and sells premium natural health products and has numerous distributorships in international markets. Ms. Liu was appointed Queen’s Counsel by Order-in- Council in December 2016.

 

 

Joel Lalancette | Master Grower

 

Mr. Lalancette brings with him thirteen years of experience in the greenhouse industry. He is an integrated operator who has been a leader in establishing numerous greenhouse businesses. His most recent experience saw him establish himself as one of Quebec’s largest producers of microgreens. Mr. Lalancette has vast knowledge and experience in large-scale greenhouse projects and is an expert in multi-zone, computer-controlled climate systems, hydroponic, aeroponic, and traditional soil systems.

 

 

Fabian Garcia | Weedon Project Manager

 

Mr. Garcia brings with him 15 years of experience in the oil and gas and petrochemical industry. He has served in a number of senior roles including Area Manager, Operations Manager, and General Manager. Mr. Garcia has a strong background in strategic planning, operations, restructuring, business development, and project start-ups. He has lived and worked in China, Qatar, Iraq, UAE, United States, Italy and Canada. He has a degree in Business Administration Marketing from Bishop’s University. Mr. Garcia will be responsible for the planning and build out of the Weedon project effective immediately.

 

Source:  http://www.mym.ca/

Disclaimer

FN Media Group LLC (FNMG) owns and operates FinancialNewsMedia.com (FNM) which is a third party publisher that disseminates electronic information through multiple online media channels. FNMG’s intended purposes are to deliver market updates and news alerts issued from private and publicly trading companies as well as providing coverage and increased awareness for companies that issue press to the public via online newswires. FNMG and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made in this release. Information in this release is derived from a variety of sources that may or may not include the referenced company’s publicly disseminated information. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. While this information is believed to be reliable, such reliability cannot be guaranteed. FNMG disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. This release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. This release is not without bias, and is considered a conflict of interest if compensation has been received by FNMG for its dissemination. To comply with Section 17(b) of the Securities Act of 1933, FNMG shall always disclose any compensation it has received, or expects to receive in the future, for the dissemination of the information found herein on behalf of one or more of the companies mentioned in this release. For current services performed FNMG has been compensated forty nine hundred dollars for MYM Nutraceuticals Inc.current news coverage by a non-affiliated third party.  FNMG HOLDS NO SHARES OF MYM Nutraceuticals Inc.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.

Sign Up & Get FREE News Alerts From FNM Today!